Government Forms 3-Member Panel to Review Pharma Marketing Practices

What happened

The Department of Pharmaceuticals, functioning under the Ministry of Chemicals and Fertilizers, has officially constituted a high-level three-member committee to thoroughly review the existing pharmaceutical marketing framework in India. This panel aims to recommend comprehensive measures to curb unethical marketing practices and strengthen monitoring, oversight, and enforcement mechanisms across the sector.

The committee is chaired by Dr. M. Srinivas, Member of NITI Aayog and former Director of AIIMS Delhi. The other two distinguished members of the panel are Smt. Preeti Sudan, Former Union Health Secretary, and Dr. Naresh Trehan, Chairman and Managing Director of Medanta. The committee has been formed following directives issued earlier in October 2026 by a Supreme Court bench comprising Justice Vikram Nath and Justice Sandeep Mehta, during hearings on a writ petition concerning indirect inducements and gifts to medical practitioners.

The Terms of Reference for the committee mandate a holistic examination of all issues related to unethical marketing practices by pharmaceutical companies. The panel will assess the efficacy of existing monitoring and enforcement mechanisms, identify necessary steps to ensure transparency and accountability, and suggest appropriate regulatory, statutory, or legal frameworks if required. The committee is tasked with consulting relevant stakeholders, technical and domain experts, and institutions, and must submit its recommendations within two months from its first meeting.

📅 Important dates

📝 What candidates should do

• Note down the names of the chairperson and members of the newly constituted committee for upcoming objective-type questions in banking and civil services exams.
• Revise the ministry handling the Department of Pharmaceuticals and understand the regulatory background of UCPMP 2015 and UCPMP 2024.
• Practice related current affairs questions focusing on Supreme Court interventions and healthcare sector governance.

🔍 PrepZen analysis

The formation of this high-level committee marks a crucial regulatory step by the Government of India to address longstanding concerns regarding indirect inducements, gifts, and unethical promotional practices by pharmaceutical companies targeting healthcare professionals. Chaired by NITI Aayog Member Dr. M. Srinivas and comprising expert administrators and medical leaders like Preeti Sudan and Dr. Naresh Trehan, the panel brings profound domain expertise to overhaul regulatory compliance.

For aspirants preparing for competitive examinations such as UPSC, State PSCs, and Banking exams, this news highlights the intersection of judicial oversight, public health policy, and administrative governance. Questions from this topic are likely to focus on the committee's composition, its chairperson, the parent ministry, and the broader regulatory context of the Uniform Code for Pharmaceutical Marketing Practices (UCPMP).

✍️ Practice questions

❓ FAQs

Prepared by PrepZen for exam preparation. Consult the linked sources for original announcements and current details. Corrections policy. Spotted an error? Write to prepzen.app@gmail.com.